#USA #New York #Class Action #Pomerantz LLP #Rafael Holdings

Pomerantz Law Firm Investigates Rafael Holdings, Inc.

In a recent announcement, Pomerantz LLP declared that it is conducting an investigation relating to potential claims on behalf of investors associated with Rafael Holdings, Inc. (NYSE: RFL), a company that has recently come under scrutiny for its financial practices. The firm is advising investors to reach out for further information regarding this investigation, which focuses on issues regarding possible securities fraud and other unlawful business dealings.

Background on Rafael Holdings, Inc.

Rafael Holdings has been in the spotlight due to its recent press release dated September 30, 2026, disclosing key trial results from its subsidiary, Cyclo Therapeutics, LLC. The data revealed from the pivotal Phase 3 TransportNPC™ study aimed at assessing the efficacy of their treatment, Trappsol® Cyclo™ (an intravenous solution), in patients diagnosed with Niemann-Pick Disease Type C (NPC). However, the press release indicated that the trial’s primary endpoint did not achieve statistical significance, which raised red flags among investors. Following this announcement, Rafael’s stock price plunged significantly—falling by $0.71, or 34.98%, closing the day at just $1.32 per share.

The Role of Pomerantz LLP

Pomerantz LLP, recognized for its formidable presence in corporate, securities, and antitrust class litigation, has made a name for itself since its inception. Founded by Abraham L. Pomerantz, often referred to as the dean of the class action bar, the firm has spent over 85 years advocating for the victims of corporate misconduct and securities violations. Their experience positions them as one of the leading firms in this sector, having secured substantial damages on behalf of class members involved in securities litigation.

Implications for Investors

The ramifications of this investigation are significant for those who invested in Rafael Holdings. Investors are being urged to assess their options and understand their rights in the context of this unfolding situation. The investigation aims to clarify whether Rafael Holdings and its management violated securities laws and what that means for shareholders who may have suffered as a result.

For those who linger with uncertainties about the investigation or who seek to explore legal recourse, Pomerantz encourages contacting Danielle Peyton at their office via email or by phone directly at 646-581-9980, ext. 7980.

Final Thoughts

As the situation develops, it is crucial for all stakeholders—especially shareholders of Rafael Holdings—to remain informed and proactive. Monitoring updates from Pomerantz and engaging with legal resources can be beneficial for those navigating potential claims related to their investments. The climate of corporate accountability is vital for ensuring fair practices in the market, and investigations like that of Pomerantz LLP are essential components in upholding these principles.